Our unique approach lies in combining scientific rigor with nutraceuticals, focusing initially on the potent antioxidant, anti-inflammatory, and anti-angiogenic properties of green tea extracts (GTEs). We exclusively source the leaves of Camellia sinensis from the spring harvest of tea sprouts, the part of the phytocomplex rich in bioactive ingredients. Our rigorous SOPs require that the plant extracts are regularly tested for contamination, microbiological purity, and obtained through sustainable practices. Our proprietary extract, Theaphenon E^®, has the highest concentration of green tea catechins (about 90%) and of epigallocatechin gallate (about 65%) currently available on the market. The efficacy of our proprietary formulations is backed by clinical research, demonstrating their safety and benefits for human use.